Loading company
Mesa Laboratories Inc.
MLAB · Nasdaq · Technology · Scientific and Technical Instruments
Next earnings: November 5, 2026
$130.52-1.9%Sep 29 close
- 1M
- +1.2%
- 6M
- +53.9%
- 1Y
- +96.0%
- 5Y
- -57.5%
MLAB · Nasdaq · Technology · Scientific and Technical Instruments
Next earnings: November 5, 2026
$130.52-1.9%Sep 29 close
Mesa Laboratories Inc. is scheduled to report next on November 5, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $60.1M | $59.5M | +1.00% |
| Profit | $2.8M | $4.7M | -40.32% |
| Profit per share | $0.49 | $0.85 | -42.35% |
| Free Cash Flow | $14.2M | $884K | +1,503.73% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“I joined Mesa about one hundred days ago. I did not spend my time writing a vision statement, I spent it inside the company, with our people and our customers. What I found is a set of durable, regulation-embedded franchises with real and growing earnings power, and fixable execution problems we have already begun to fix. My focus is disciplined execution and consistent, profitable growth across our four divisions. In November, alongside first-half results, I will give full-year guidance,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Mesa Laboratories Inc.’s Item 2.02 8-K filed August 10, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Mesa Laboratories Inc. has no earnings call transcript available.